{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:20:53Z","timestamp":1788175253099,"version":"build-2803163510"},"reference-count":27,"publisher":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:p>Background: Gout is a common form of inflammatory arthritis. Objectives: This study aimed to explore the mechanism of Erding granules in gout. Methods: The anti-gout components and targets of Erding granules were identified using network pharmacology. Molecular docking predicted the degree of binding between compounds and targets. Cell experiments confirmed changes in target expression levels and preliminary anti-inflammatory effects. Results: Erding granules contain 14 potential active ingredients and 18 possible targets for fighting gout. Using KEGG and GO enrichment analyses, two signaling pathways were identified, namely PI3K\/AKT and MAPK. Two cellular components, GO: 0035866, alpha-beta3 integrin-PKCalpha complex and GO: 0035867, alpha-beta3 integrin-IGF-1-IGF1R complex, were identified. The key signaling pathways and two cellular components were traced to identify the corresponding genes and experiments were designed to verify them. Through RT-qPCR, it was found that monosodium urate (MSU) can cause increases in the expression levels of INSR, PRKCA and IGF1R mRNA; however, Erding granules can reverse these increases. Under the action of Erding granules, the increased release of IL-1? and IL-18 induced by MSU was reversed. Conclusion: Erding granules may alleviate gout by reducing the release of pro-inflammatory factors via targeting INSR, PRKCA and IGF1R.<\/jats:p>","DOI":"10.36721\/pjps.2026.39.8.232.1","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:02:51Z","timestamp":1781010171000},"source":"Crossref","is-referenced-by-count":0,"title":["Exploring The Anti-Gout Mechanism Of Erding Granules Based On Network Pharmacology And Experimental Verification"],"prefix":"10.36721","author":[{"given":"Guanglei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22735","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"ref0","unstructured":"Ashiq K, Bajwa MA, Tanveer S, Qayyum M, Ashiq S, Khokhar R and Abid F (2021). A comprehensive review on gout: The epidemiological trends, pathophysiology, clinical presentation, diagnosis and treatment. J. Pak. Med. Assoc., 71(4): 1234-1238."},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Chen R, Yin C, Fang J and Liu B (2021). The NLRP3 inflammasome: An emerging therapeutic target for chronic pain. J. Neuroinflammation, 18(1): 84.","DOI":"10.1186\/s12974-021-02131-0"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Chou YT, Li CH, Shen WC, Yang YC, Lu FH, Wu JS and Chang CJ (2020). Association of sleep quality and sleep duration with serum uric acid levels in adults. PLoS One, 15(9): e0239185.","DOI":"10.1371\/journal.pone.0239185"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Clerk A and Sugden PH (2022). The insulin receptor family in the heart: New light on old insights. Biosci. Rep., 42(7): BSR20221212.","DOI":"10.1042\/BSR20221212"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Dalbeth N, Gosling AL, Gaffo A and Abhishek A (2021). Gout. Lancet, 397(10287): 1843-1855.","DOI":"10.1016\/S0140-6736(21)00569-9"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Deng W, Wu L, Xiao Z, Li Y, Zheng Z and Chen S (2023). Structural characterization and anti-inflammatory activity of polysaccharides from Tremella fuciformis on monosodium urate-stimulated RAW264.7 macrophages. Foods, 12(24): 4398.","DOI":"10.3390\/foods12244398"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Fang S, Dong L, Liu L, Guo J, Zhao L, Zhang J, Bu D, Liu X, Huo P, Cao W, Dong Q, Wu J, Zeng X, Wu Y and Zhao Y (2020). HERB: A high-throughput experiment- and reference-guided database of traditional Chinese medicine. Nucleic Acids Res., 49(D1): D1197-D1206.","DOI":"10.1093\/nar\/gkaa1063"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Heo J, Schifino AG, McFaline-Figueroa J, Miller DL, Hoffman JR, Noble EE, Greising SM and Call JA (2023). Differential effects of Western diet and traumatic muscle injury on skeletal muscle metabolic regulation in male and female mice. J. Cachexia Sarcopenia Muscle, 14(6): 2835-2850.","DOI":"10.1002\/jcsm.13361"},{"key":"ref8","unstructured":"Hua L, Zhi-Gang C, Hai-Lin B, Ai-Chun W, Xiao-Jian W, Xiao-Lin F and Wan-Hong LI (2022). Clinical efficacy of gouty tea on chronic gouty arthritis and its effects on serum vascular endothelial function and inflammatory cytokines. Pak. J. Pharm. Sci., 35(4): 999-1006."},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Kang HS, Lee NE, Yoo DM, Han KM, Hong JY, Choi HG, Lim H, Kim JH, Kim JH, Cho SJ, Nam ES, Park HY, Kim NY, Baek SU, Lee JY and Kwon MJ (2023). An elevated likelihood of stroke, ischemic heart disease, or heart failure in individuals with gout: A longitudinal follow-up study utilizing the National Health Information database in Korea. Front. Endocrinol. (Lausanne), 141195888.","DOI":"10.3389\/fendo.2023.1195888"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Liu Y, Luo L and Gao Z (2024). J-shaped relationship between Chinese visceral adiposity index and hyperuricemia: A cross-sectional study. Lipids Health Dis., 23(1): 267.","DOI":"10.1186\/s12944-024-02247-1"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Liu Y, Yang X, Gan J, Chen S, Xiao Z-X and Cao Y (2022). CB-Dock2: Improved protein\u2013ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res., 50(W1): W159-W164.","DOI":"10.1093\/nar\/gkac394"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Marcil J, Harbour D, Houle MG, Naccache PH and Bourgoin S (1999). Monosodium urate-crystal-stimulated phospholipase D in human neutrophils. Biochem. J., 337(Pt 2): 185-192.","DOI":"10.1042\/bj3370185"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Oh KK, Adnan M and Cho DH (2021). Network pharmacology study on Morus alba l. leaves: Pivotal functions of bioactives on ras signaling pathway and its associated target proteins against gout. Int. J Mo.l Sci., 22(17): 9372.","DOI":"10.3390\/ijms22179372"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, Xu X, Li Y, Wang Y and Yang L (2014). TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. J. Cheminform, 6: 13.","DOI":"10.1186\/1758-2946-6-13"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Sayers EW, Bolton EE, Brister JR, Canese K, Chan J, Comeau DC, Connor R, Funk K, Kelly C, Kim S, Madej T, Marchler-Bauer A, Lanczycki C, Lathrop S, Lu Z, Thibaud-Nissen F, Murphy T, Phan L, Skripchenko Y, Tse T, Wang J, Williams R, Trawick BW, Pruitt KD and Sherry ST (2022). Database resources of the National Center for Biotechnology Information. Nucleic Acids Res., 50(D1): D20-d26.","DOI":"10.1093\/nar\/gkab1112"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Shi Y, Tao M, Ma X, Hu Y, Huang G, Qiu A, Zhuang S and Liu N (2020). Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy. Cell Death Dis., 11(6): 467.","DOI":"10.1038\/s41419-020-2673-z"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Song S, Jia C, Li C and Ma Y (2023). The causal association between thyroid disease and gout: A Mendelian randomization study. Medicine (Baltimore), 102(44): e35817.","DOI":"10.1097\/MD.0000000000035817"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Sun X, Yang L, Sun H, Sun Y, Wei S, Han Y, Wang W, Kong L and Wang X (2023). TCM and related active compounds in the treatment of gout: The regulation of signaling pathway and urate transporter. Front Pharmacol., 141275974.","DOI":"10.3389\/fphar.2023.1275974"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, Bork P, Jensen LJ and von Mering C (2023). The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res., 51(D1): D638-d646.","DOI":"10.1093\/nar\/gkac1000"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Werner H (2023). The IGF1 signaling pathway: From basic concepts to therapeutic opportunities. Int. J. Mol. Sci., 24(19): 14882.","DOI":"10.3390\/ijms241914882"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Wu C, Zhang Z, Bai L, Lei S, Zou M, Bao Z, Ren Z, Liu K, Gong HH, Ma W and Chen L (2024). Piper longum L. ameliorates gout through the MAPK\/PI3K-AKT pathway. J. Ethnopharmacol., 330118254.","DOI":"10.1016\/j.jep.2024.118254"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Xu Y, Song D, Wang W, Li S, Yue T, Xia T and Shi Y (2023). Clec12a inhibits MSU-induced immune activation through lipid raft expulsion. Life Sci. Alliance, 6(9): e202301938.","DOI":"10.26508\/lsa.202301938"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Yan D, Zheng G, Wang C, Chen Z, Mao T, Gao J, Yan Y, Chen X, Ji X, Yu J, Mo S, Wen H, Han W, Zhou M, Wang Y, Wang J, Tang K and Cao Z (2021). HIT 2.0: An enhanced platform for Herbal Ingredients' Targets. Nucleic Acids Res., 50(D1): D1238-D1243.","DOI":"10.1093\/nar\/gkab1011"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Zhang H, Jiang H, Zhao M, Xu Y, Liang J, Ye Y and Chen H (2022). Treatment of gout with TCM using turmeric and corn silk: A concise review article and pharmacology network analysis. Evid. Based Complement. Alternat. Med., 20223143733.","DOI":"10.1155\/2022\/3143733"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y and Zhu F (2024). TTD: Therapeutic target database describing target druggability information. Nucleic Acids Res., 52(D1): D1465-d1477.","DOI":"10.1093\/nar\/gkad751"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Zitt E, Fischer A, Lhotta K, Concin H and Nagel G (2020). Sex- and age-specific variations, temporal trends and metabolic determinants of serum uric acid concentrations in a large population-based Austrian cohort. Sci. Rep., 10(1): 7578.","DOI":"10.1038\/s41598-020-64587-z"}],"container-title":["Pakistan Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:04:56Z","timestamp":1788174296000},"score":1,"resource":{"primary":{"URL":"https:\/\/pjps.pk\/single-article?id=7837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":27,"URL":"https:\/\/doi.org\/10.36721\/pjps.2026.39.8.232.1","relation":{},"ISSN":["1011-601X","3105-9686"],"issn-type":[{"value":"1011-601X","type":"print"},{"value":"3105-9686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]}}}